(Press-News.org) (NEW YORK, NY and BRUSSELS, BELGIUM) - June 17, 2024 - The 2024 Global NF Conference, organized by the Children’s Tumor Foundation (CTF) and the European NF Group, and hosted by Children's Tumor Foundation Europe, is the foremost assembly defining the scientific and medical future of the genetic conditions neurofibromatosis and schwannomatosis (known collectively as NF). This global gathering, taking place from June 20-25 at THE EGG in Brussels, Belgium, will connect over 1,000 attendees for up-to-date knowledge and insights in the growing fields of NF research and care. It’s a pivotal moment in NF research, offering a front-row seat to the significant progress being made to accelerate the development of effective treatments for patients.
A New Era for NF Research and Care
NF, encompassing neurofibromatosis type 1 (NF1), and all forms of schwannomatosis (SWN), including NF2-related schwannomatosis (NF2-SWN), affects approximately 4 million people worldwide. These genetic conditions cause tumors to grow on nerves throughout the body, leading to blindness, deafness, bone abnormalities, disfigurement, learning disabilities, disabling pain, and cancer. The Global NF Conference aims to redefine the future of NF research and care, accelerating the path to effective therapies and improving patient outcomes.
Unprecedented Depth and Breadth of Content
For the first time, the conference will allocate a full-day to each of the main topics, allowing for an in-depth exploration of critical areas such as gene therapy, comprehensive care, novel therapeutics, artificial intelligence, and biomarker discovery. Highlights include:
Young Investigator Day (June 20), a dedicated session to support and mentor up-and-coming researchers, fostering the next generation of NF scientists.
Patient Day (June 21), an opportunity for patients to engage directly with researchers and clinicians, featuring educational sessions on diagnostics, lifestyle behaviors, and clinical trial participation.
Renowned Keynote Speakers
Five keynote sessions will anchor the conference, featuring leading scientific innovators:
Gene Therapy Keynote: Dr. Luigi Naldini (San Raffaele University, Italy) on translating gene therapy from bench to bedside
Comprehensive Care Keynote: Dr. Abby Rosenberg (Boston Children's Hospital / Harvard University) on the science and art of resilience
Schwannomatosis (SWN) Keynote: Dr. Andrew Rice (Imperial College Longon, UK) on managing chronic neuropathic pain
Novel Therapeutics Keynote: Dr. Daniel Nomura (University of California Berkeley) on innovative chemoproteomic platforms
AI and Biomarkers Keynote: Dr. Casey Greene (University of Colorado) on the expanding role of AI in research and care
A Global Gathering of Experts and Innovators
The conference will draw a diverse group of attendees, including research scientists, medical professionals, pharmaceutical and biotech companies, investors, public and private funders, government agencies, media, and patient representatives. This convergence of expertise will drive forward the basic, translational, and clinical research necessary to conquer NF.
Special Sessions and Awards
Opening Remarks (June 21): Nathalie Moll (Director General, European Federation of Pharmaceutical Industries and Associations - EFPIA) will open the conference, contributing her insights on innovation and collaboration
Fireside Chat (June 24): A unique dialogue between Dr. Niklas Blomberg (Innovative Health Initiative Executive Director), and Magda Chlebus (EFPIA Executive Director Scientific & Regulatory Affairs), moderated by Dr. Annette Bakker, Children's Tumor Foundation CEO, focusing on public-private partnerships in rare disease research.
Friedrich von Recklinghausen Award (June 21): Honoring Dr. Rosalie Ferner (Guys and St. Thomas NHS Foundation Trust London) for her significant contributions to NF research and care.
For more information about the Global NF Conference, visit nfconference.org. For details about the Children’s Tumor Foundation, visit ctf.org.
About the Children’s Tumor Foundation
The Children’s Tumor Foundation is the world’s leading organization dedicated to funding and driving innovative research that will result in effective treatments for the millions of people worldwide living with NF, a group of genetic conditions that cause tumors to grow on nerves throughout the body. Through collaboration with the scientific community, pharmaceutical and biotech industries, and other key partners, we work diligently to accelerate research and development efforts, ensuring that promising treatments reach those who need them. One in every 2,000 people is born with some type of neurofibromatosis or schwannomatosis, which may lead to blindness, deafness, bone abnormalities, disfigurement, learning disabilities, disabling pain, or cancer. NF affects all populations equally, and while there is no cure yet, the Children’s Tumor Foundation mission of driving research, expanding knowledge, and advancing care for the NF community fosters our vision of one day ending NF. For more information, please visit: ctf.org.
END
Children’s Tumor Foundation presents the 2024 Global NF Conference in Brussels: Shaping what’s next for NF
2024-06-17
ELSE PRESS RELEASES FROM THIS DATE:
Researchers discover potential mole reversal therapy in rare condition
2024-06-17
Francis Crick Institute press
Peer reviewed
Experimental study
Cells, people and animals
*Case studies available for interview*
Researchers discover potential mole reversal therapy in rare condition
“Knowing there has been a huge step forward in the CMN research and there could be a chance of Ada’s CMN being reversed and possibly reducing Ada’s risk of developing melanoma, has blown our expectations out the water.” Ada’s Mum and Dad, Rachelle and Greg
Researchers at the Francis Crick Institute, UCL Great Ormond Street Institute for Child Health and Great Ormond Street ...
Threefold improvement of solid oxide fuel cell in 4 minutes
2024-06-17
Dr. Yoonseok Choi from the Hydrogen Convergence Materials Laboratory at the Korea Institute of Energy Research (KIER), in collaboration with Professor WooChul Jung from the Department of Materials Science and Engineering at KAIST and Professor Beom-Kyung Park from the Department of Materials Science and Engineering at Pusan National University, has successfully developed a catalyst coating technology that significantly improves the performance of solid oxide fuel cells (SOFCs) in just 4 minutes.
Fuel cells are gaining attention as highly efficient and clean energy devices driving the hydrogen economy. Among them, solid ...
New initiative aims to help tens of thousands with recurrent pericarditis
2024-06-17
DALLAS, June 17, 2024 — About 40,000 people in the United States experience recurrent pericarditis, or inflammation of the sac-like structure that protects the heart, which can cause chest pain and may lead to fluid buildup around the heart muscle.
The American Heart Association, celebrating 100 years of lifesaving service in 2024, is launching a three-year initiative to empower patients and equip health care providers with up-to-date science to inform recurrent pericarditis care decisions.
The Addressing Recurrent Pericarditis initiative, supported by Kiniksa Pharmaceuticals, aims to improve diagnosis, treatment and quality of life for those with ...
Multiple new awards recognize NCCN as exceptional source for information for cancer patients and caregivers
2024-06-17
PLYMOUTH MEETING, PA [June 17, 2024] — The National Comprehensive Cancer Network® (NCCN®) today announced new recognitions for the award-winning library of NCCN Guidelines for Patients® and NCCN Patient Webinars. The NCCN Guidelines for Patients: Colon Cancer earned a Gold Award from Hemes Creative Awards for Electronic Media/Social Media/Interactive Media/Digital Publications/Messaging. The NCCN Guidelines for Patients: Kidney Cancer earned an Award of Distinction from The Communicator Awards for Print Content—Medical. Additionally, the NCCN Patient Webinar for Uterine Cancer has been named a Gold Winner from the Viddy Awards while the NCCN Patient Webinar ...
Study shows a high-fat diet may fuel anxiety
2024-06-17
When stressed out, many of us turn to junk food for solace. But new University of Colorado Boulder research suggests this strategy may backfire.
The study found that in animals, a high-fat diet disrupts resident gut bacteria, alters behavior and, through a complex pathway connecting the gut to the brain, influences brain chemicals in ways that fuel anxiety.
“Everyone knows that these are not healthy foods, but we tend to think about them strictly in terms of a little weight gain,” said lead author Christopher Lowry, a professor of integrative physiology at CU Boulder. “If you understand that they also impact your brain in a way that ...
Novel method for measuring nano/microplastic concentrations in soil using spectroscopy
2024-06-17
Nano and microplastics are a well-known menace, found practically everywhere in nature, including soil, oceans, drinking water, air, and even the human body. Studies show that soils in particular hold a significant portion of N/MPs. The problem with these N/MPs is their microscopic size, which allows them to easily migrate through soil into the ground or freshwater bodies due to rainwater leaching. From there, they enter the human body. Hence, it is imperative to understand the distribution and movement of the soil’s N/MPs to gauge their threat and mitigate it.
Current ...
Poll: Majority of Americans say key COVID-19 policies were a good idea—but views of individual policies vary
2024-06-17
Embargoed for release: Monday, June 17, 6:00 AM ET
Boston, MA—A majority of Americans say that several key policies to stop the spread of COVID-19 were generally a good idea in hindsight, according to a new national poll by Harvard T.H. Chan School of Public Health and the de Beaumont Foundation. The poll also found, however, that views varied across policies, and many say the policies had negative impacts.
The poll, U.S. Views on Pandemic Policies: Lessons for Emerging Outbreaks, was conducted March 21 to April 2, 2024, among a nationally representative, probability-based sample of 1,017 adults ages 18 or older.
A majority of Americans say four key pandemic policies ...
Six distinct types of depression identified in Stanford Medicine-led study
2024-06-17
In the not-too-distant future, a screening assessment for depression could include a quick brain scan to identify the best treatment.
Brain imaging combined with machine learning can reveal subtypes of depression and anxiety, according to a new study led by researchers at Stanford Medicine. The study, to be published June 17 in the journal Nature Medicine, sorts depression into six biological subtypes, or “biotypes,” and identifies treatments that are more likely or less likely to work ...
Chronic high blood pressure during pregnancy doubled between 2008 and 2021 in the U.S.
2024-06-17
Research Highlights:
The number of individuals in the United States who had chronic hypertension or chronic high blood pressure during pregnancy doubled between 2008 and 2021, according to a nationwide review of private health insurance claims.
Treatment rates for chronic hypertension during pregnancy remained relatively low but stable during the same time, with only about 60% of the individuals receiving (filling prescriptions for) antihypertensive medications.
The researchers say these findings underscore the need to adhere to clinical guidelines for accurate diagnosis and treatment of high blood pressure before and during pregnancy.
Embargoed until 4 ...
Pancreatic cancer’s cellular amnesia
2024-06-17
Things aren’t always as they seem. Take pancreatic cancer, for example. In up to one in 10 cases, researchers have documented a peculiar characteristic. Some of the pancreatic cells appear to have lost their identity. It’s as if they forget what they are.
“This is very bizarre. You see pancreatic cancer, which usually somewhat resembles the original organ, losing those features and basically becoming akin to skin or esophagus—these other very unrelated tissues, " explains ...